Does neoadjuvant treatment before oncologic esophagectomy affect the postoperative quality of life? A prospective, longitudinal outcome study

Diseases of the Esophagus

Volumn 28, Issue 7, 2015, Pages 652-659

  Hauser, C ^a   Patett, C ^a   von Schoenfels, W ^a   Heits, N ^a   Schafmayer, C ^a   Malchow, B ^a   Hampe, J ^b   Schniewind, B ^c   Becker, T ^a   Egberts, J H ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c Municipal Hospital of Lueneburg   (Germany)

Author keywords

Esophageal cancer; Esophagectomy; Esophagogastrostomy; Neoadjuvant treatment; Quality of life

Indexed keywords

CISPLATIN;

ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADULT; ARTICLE; CANCER MORTALITY; CONTROLLED STUDY; ESOPHAGOGASTROSTOMY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR VOLUME; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; MIDDLE AGED; MORTALITY; NEOADJUVANT THERAPY; PSYCHOLOGY;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL RATE;

EID: 84943661601     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12257     Document Type: Article

References (41)

1. van Hagen P, Hulshof M C, van Lanschot J J etal. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074-2084.
2. Gebski V, Burmeister B, Smithers B M etal. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226-234.
3. Greer S E, Goodney P P, Sutton J E, Birkmeyer J D. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 2005; 137: 172-177.
4. Sjoquist K M, Burmeister B H, Smithers B M etal. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 2011; 12: 681-692.
5. Lordick F. Neoadjuvant therapy for squamous cell carcinoma of the esophagus. Chirurg 2005; 76: 1025-1032.
6. Patel A N, Sutton S W, Livingston S etal. Clinical benefits of leukocyte filtration during valve surgery. Am J Surg 2003; 186: 636-639, discussion 639-640.
7. Urschel J D, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185: 538-543.
8. McLarty A J, Deschamps C, Trastek V F etal. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 1997; 63: 1568-1572.
9. Schmidt C E, Bestmann B, Kuchler T etal. Quality of life associated with surgery for esophageal cancer: differences between collar and intrathoracic anastomoses. World J Surg 2004; 28: 355-360.
10. Brooks J A, Kesler K A, Johnson C S etal. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. J Surg Oncol 2002; 81: 185-194.
11. Baba M, Aikou T, Natsugoe S etal. Appraisal of ten-year survival following esophagectomy for carcinoma of the esophagus with emphasis on quality of life. World J Surg 1997; 21: 282-285, discussion 286.
12. Conroy T, Marchal F, Blazeby J M. Quality of life in patients with oesophageal and gastric cancer: an overview. Oncology 2006; 70: 391-402.
13. Blazeby J M, Brookes S T, Alderson D. The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut 2001; 49: 227-230.
14. McKernan M, McMillan D C, Anderson J R etal. The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. Br J Cancer 2008; 98: 888-893.
15. Lipscomb J, Donaldson M S, Arora N K etal. Cancer outcomes research. J Natl Cancer Inst Monogr 2004; 33: 178-197.
16. Beitz J, Gnecco C, Justice R. Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective. J Natl Cancer Inst Monogr 1996; 20: 7-9.
17. Jacobs M, Macefield R C, Elbers R G etal. Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery. Qual Life Res 2014; 23: 1155-1176.
18. Talsma K, van Hagen P, Grotenhuis B A etal. Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer. Ann Surg Oncol 2012; 19: 2142-2148.
19. Siewert J R, Stein H J. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-1459.
20. Kuechler T. Quality of Life Research in Oncology. Quality of Life and Health: Concepts, Methods and Applications. Vienna: Blackwell Wissenschafts-Verlag, 1995; 89-96.
21. Fayers B, Curran D, Groenvold M. EORTC QLQ-C30 Scoring manual, 1999.
22. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37: 1345-1351.
23. Fayers P M, Aaronson N K, Bjordal K etal. EORTC QLQ-C30 Scoring manual, 2nd edn. Brussels: European Organisation for Research and Treatment of Cancer, 1999.
24. Osoba D, Rodrigues G, Myles J etal. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139-144.
25. Blazeby J M. Measurement of outcome. Surg Oncol 2001; 10: 127-133.
26. Stein H J, von Rahden B H, Siewert J R. Survival after oesophagectomy for cancer of the oesophagus. Langenbecks Arch Surg 2005; 390: 280-285.
27. Djarv T, Metcalfe C, Avery K N etal. Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer. J Clin Oncol 2010; 28: 1666-1670.
28. de Boer A G, van Lanschot J J, van Sandick J W etal. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 2004; 22: 4202-4208.
29. Blazeby J M, Farndon J R, Donovan J, Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000; 88: 1781-1787.
30. Viklund P, Wengstrom Y, Rouvelas I etal. Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 2006; 42: 1407-1414.
31. van Knippenberg F C, Out J J, Tilanus H W etal. Quality of life in patients with resected oesophageal cancer. Soc Sci Med 1992; 35: 139-145.
32. Kranzfelder M, Schuster T, Geinitz H etal. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Br J Surg 2011; 98: 768-783.
33. Spigel D R, Greco F A, Meluch A A etal. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 2010; 28: 2213-2219.
34. Egberts J H, Schniewind B, Bestmann B etal. Impact of the site of anastomosis after oncologic esophagectomy on quality of life - a prospective, longitudinal outcome study. Ann Surg Oncol 2008; 15: 566-575.
35. Schniewind B, Bestmann B, Kurdow R etal. Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses. Ann Surg Oncol 2006; 13: 1403-1411.
36. Kahlke V, Bestmann B, Schmid A etal. Palliation of metastatic gastric cancer: impact of preoperative symptoms and the type of operation on survival and quality of life. World J Surg 2004; 28: 369-375.
37. Sprangers M A, Van Dam F S, Broersen J etal. Revealing response shift in longitudinal research on fatigue - the use of the thentest approach. Acta Oncol 1999; 38: 709-718.
38. de Boer A G, van Lanschot J J, Stalmeier P F etal. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res 2004; 13: 311-320.
39. de Haes J C, van Knippenberg F C, Neijt J P. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990; 62: 1034-1038.
40. Spitzer W O, Dobson A J, Hall J etal. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis 1981; 34: 585-597.
41. Blazeby J M, Alderson D, Winstone K etal. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Eur J Cancer 1996; 32A: 1912-1917.